Filter
1143
Text search:
European
Medicine
Agency
Featured
118
216
Language
Document type
483
304
176
90
40
20
15
9
3
1
1
Countries
66
66
37
23
21
19
19
19
17
16
16
15
13
13
12
12
11
10
10
10
10
9
9
9
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
297
108
74
56
55
22
13
Toolboxes
120
97
89
88
69
46
46
36
33
33
29
26
25
24
21
21
20
19
11
10
8
7
6
4
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t
...
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the
...
Providing community-based mental health services position paper
EMCDDA Insights - 11
Accessed: 14.03.2019
Harm reduction: evidence, impacts and challenges
-10-
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re
...
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project was developed in the context of ECDC’s support fo
...
ECDC Technical Document. The aim of this document is to provide an operational tool to facilitate the structured and reproducible development of rapid risk assessments for communicable disease incidents. The target audience is primarily experts responsible for the rapid assessment of communicable di
...
This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes.
The aim of this guidance is to suppo
...
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended
...
An update from the EU Early Warning System
EU Compass for Action on Mental Health and Well-being
Scientific Paper
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
